Trexquant Investment LP - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 207 filers reported holding AMICUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$729,308
-75.5%
59,976
-77.6%
0.02%
-78.0%
Q1 2023$2,971,355
+75.7%
267,931
+93.5%
0.08%
+70.8%
Q4 2022$1,690,890
+481.1%
138,484
+411.4%
0.05%
+269.2%
Q2 2022$291,000
+157.5%
27,077
+129.8%
0.01%
+44.4%
Q3 2021$113,000
-61.4%
11,782
-61.3%
0.01%
-64.0%
Q2 2021$293,000
-62.8%
30,425
-61.9%
0.02%
-65.3%
Q1 2021$788,000
-37.5%
79,793
+46.2%
0.07%
-46.3%
Q4 2020$1,261,000
+333.3%
54,592
+165.2%
0.13%
+605.3%
Q3 2020$291,000
-10.5%
20,584
-41.4%
0.02%
-20.8%
Q1 2020$325,000
+3.2%
35,155
-10.5%
0.02%
-11.1%
Q3 2019$315,000
-63.7%
39,260
-43.5%
0.03%
-65.4%
Q2 2019$867,000
+155.8%
69,475
+207.8%
0.08%
+225.0%
Q1 2018$339,000
-6.9%
22,571
-10.6%
0.02%
-40.0%
Q4 2017$364,000
+19.7%
25,261
+25.3%
0.04%
-48.1%
Q3 2017$304,000
-28.8%
20,160
-52.5%
0.08%
-34.2%
Q2 2017$427,000
-13.9%
42,400
-39.0%
0.12%
+82.8%
Q1 2017$496,000
+126.5%
69,564
+134.5%
0.06%
+30.6%
Q3 2016$219,000
-54.7%
29,662
-66.5%
0.05%
-22.2%
Q2 2016$483,000
+151.6%
88,486
+288.7%
0.06%
+186.4%
Q1 2016$192,000
-88.2%
22,766
-80.2%
0.02%
-88.0%
Q2 2015$1,628,000
+130.3%
115,100
+77.1%
0.18%
+154.2%
Q1 2015$707,000
+18.6%
65,000
-9.3%
0.07%
-31.4%
Q4 2014$596,00071,7000.10%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Morgenthaler Management Partners IX, LLC 1,783,948$17,304,00018.83%
FRAZIER MANAGEMENT LLC 2,918,291$28,307,00011.84%
Avoro Capital Advisors LLC 3,515,611$34,101,00011.75%
Perceptive Advisors 15,239,444$147,823,00010.94%
Redmile Group, LLC 10,280,620$99,722,0007.46%
ACUTA CAPITAL PARTNERS, LLC 1,502,661$14,576,0006.97%
SECTORAL ASSET MANAGEMENT INC 7,973,436$77,342,0003.30%
Asymmetry Capital Management, L.P. 195,206$1,893,0002.86%
Convector Capital Management, LP 210,500$2,042,0001.92%
Palo Alto Investors LP 3,551,173$34,446,0001.92%
View complete list of AMICUS THERAPEUTICS INC shareholders